Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
3decision® serves as a cloud-based repository for protein structures, focusing on efficient management of structural data and offering sophisticated analytics to support teams involved in the discovery of small molecules and biologics, thereby expediting the process of structure-based drug design.
The platform consolidates and standardizes both experimental and computational protein structures sourced from publicly available databases such as RCSB PDB and AlphaFoldDB, in addition to proprietary datasets, and accommodates formats like PDBx/mmCIF and ModelCIF. This comprehensive approach guarantees seamless access to a variety of structural formats including X-Ray, NMR, cryo-EM, and modeled structures, thereby promoting collaboration and bolstering research initiatives.
In addition to its storage capabilities, 3decision® enhances each entry with valuable metadata and sequence information, which encompasses details on protein-ligand interactions, antibody annotations, and specifics about binding sites. Equipped with advanced analytical instruments, the platform is capable of pinpointing druggable sites, evaluating off-target risks, and facilitating comparisons of binding sites, which collectively transform extensive structural datasets into practical insights that can drive research forward.
Furthermore, its cloud-based architecture fosters enhanced collaboration among research teams, making it easier for scientists to share findings and insights, ultimately leading to more innovative approaches in drug discovery and development.
Description
Amazon Bio Discovery is an innovative application leveraging AI to enhance the efficiency of early-stage drug discovery by fusing computational biology models with practical laboratory testing in a cohesive "lab-in-the-loop" approach. This tool empowers researchers by granting them immediate access to an extensive library of biological foundation models developed from vast biological datasets, facilitating the rapid generation and assessment of potential drug candidates, including antibodies, with improved accuracy and speed. Additionally, the platform features an integrated AI agent that allows users to engage in natural language conversations to choose suitable models, set up experiments, and fine-tune inputs, eliminating the need for advanced programming skills or complex infrastructure. Researchers can also create multi-step workflows that integrate various models, evaluate their efficacy, and share workflows among teams, thereby fostering better collaboration between computational biologists and laboratory scientists. Ultimately, this powerful tool aims to streamline the drug discovery process and enhance scientific innovation in the field.
API Access
Has API
API Access
Has API
Screenshots View All
No images available
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Discngine
Founded
2004
Country
France
Website
www.discngine.com
Vendor Details
Company Name
Amazon
Founded
1994
Country
United States
Website
aws.amazon.com/es/biodiscovery/